Cleared Traditional

K840503 - SDL LISTERIA MONOCYTOGENES CONTROL (FDA 510(k) Clearance)

Class I Microbiology device.

K840503 · Scientific Device Laboratory, Inc. · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1984
Decision
46d
Days
Class 1
Risk

K840503 is an FDA 510(k) clearance for the SDL LISTERIA MONOCYTOGENES CONTROL. Classified as Antigens, Slide And Tube, All Types, Listeria Monocytogenes (product code GSI), Class I - General Controls.

Submitted by Scientific Device Laboratory, Inc. (Mchenry, US). The FDA issued a Cleared decision on March 23, 1984 after a review of 46 days - a notably fast clearance cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3355 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Scientific Device Laboratory, Inc. devices

Submission Details

510(k) Number K840503 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 06, 1984
Decision Date March 23, 1984
Days to Decision 46 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
56d faster than avg
Panel avg: 102d · This submission: 46d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code GSI Antigens, Slide And Tube, All Types, Listeria Monocytogenes
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 866.3355
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.